North America Cell Culture Market

North America Cell Culture Market Size (2023 to 2028)

The size of the Cell Culture Market in North America is estimated to be worth USD 6.38 billion in 2023 and USD 10.29 Billion by 2028, growing at a CAGR of 10.02% during the forecast period.

Cells are the fundamental building blocks of human life. Tissue culture was developed first in the 20^th century to study cells' behavior in response to stress and other external factors, be it induced or natural. Gradually techniques developed that enabled the study of single cells and cell culture was born.

Cell culture involves the dispersal of cells into an artificial environment composed of nutrient solutions, a suitable surface for the growth of cells, and favorable conditions of temperature, humidity, and gaseous atmosphere. This enables the researcher to precisely measure the responses of the cell in use of the data in prospective drugs and analysis of carcinogenic agents and viruses. Cell cultures can be established from various sources such as blood or even small fragments of tissues, called biopsies. Other sources include lymphocytes and fibroblasts, each with its own positives.

The major factors affecting the North American cell culture market include the increasing incidence of chronic diseases, the increasing regulatory approvals for cell-culture-based vaccines, and a rise in demand for mAbs. This, along with the technological advancements in cell culture products and the growing adoption of single-use technologies, is expected to drive the market forward in the coming years.

Despite the numerous drivers for the market, factors such as ethical concerns regarding the treatment of animals as test subjects and the high costs associated with research in the field continue to hamper the market's growth.

This research report on the North American cell culture market has been segmented and sub-segmented into the following categories:

By Product:

• Equipment
  • Bioreactors
  • Cell Culture Vessels
  • Cell Culture Storage Equipment
  • Cell Culture Supporting Equipment
• Consumables
  • Sera, Media & Reagents
  • Bioreactor Accessories

By Application:

• Biopharmaceutical
  • Vaccine Production
  • Diagnostics
  • Recombinant Therapeutic Proteins
• Cancer Research
• Stem Cell Technologies
• Drug Screening and Development
• Tissue Engineering & Regenerative Medicine
• Other Applications

By End-User:

• Pharmaceutical and Biotechnology Companies
• Research Institutes

By Country: 

• The United States
• Canada
• Rest of North America

Geographically, the North American region had the highest market share globally despite having a below-average growth rate in 2022. The growth rate is the second-lowest of all the regions because most segments in the region are already in their prime state of development. The factors that affect the North American cell culture market growth are the increasing occurrence rate of chronic diseases, the rise in demand for mAbs, and regulatory approvals for cell culture-based vaccines. Therefore, the largest share is accounted by North America, which is due to the high demand for biopharmaceutical products, firmly-established healthcare systems, great adoption of advanced technology, and the rising commonness of chronic diseases, growth in pharmaceutical research and development, and also the entry of new key players in North America.

In the cell culture of North America, the developed infrastructure and the existence of international funding organizations in this region have also been instrumented in increasing the demand for the cell culture market, and these drive the market growth.

KEY MARKET PLAYERS:

Companies playing a leading role in the North America cell culture market profiled in this report are Thermo Fisher Scientific, GE Healthcare, Merck KGaA, Sartorius AG, Eppendorf AG, Lonza AG, Corning, Becton, Dickinson and Company, Promocell GmbH, and Hi-Media Laboratories.